• A comprehensive drug resource providing up-to-date information on the rapidly evolving field of cardiovascular drugs

• Exhaustive coverage of various disease conditions

• Provides the latest information with the incorporation of the latest JNC 8 guidelines and also highlights the key differences between previous and new guidelines

• Focus on newly evolving cardiovascular comorbid conditions with extensive coverage of cardiovascular disease management in patients with co-existing diabetes, dysmetabolic syndrome, and pregnancy

• Extensive use of illustrations, figures, and tables makes for easy reading and recall for use in everyday practice

• The chapter on “Future Directions” provides insight in to the exciting new role of exploring the human genome for opportunities to improve therapeutic precision in cardiovascular medicine

• Easy-to-read and user-friendly presentation merging with fluid scientific information and latest clinical data make for an enhanced reading experience

• Written by experts having extensive research and clinical experience with a hand on the pulse of this rapidly evolving field of cardiovascular pharmacology.